Resection and chemotherapy is the optimal treatment approach for patients with clinically node positive intrahepatic cholangiocarcinoma-Reference-Cited by-同舟云学术

Resection and chemotherapy is the optimal treatment approach for patients with clinically node positive intrahepatic cholangiocarcinoma

Published:2020-01 Issue:1 Volume:22 Page:129-135
ISSN:1365-182X
Container-title:HPB
language:en
Short-container-title:HPB

Author:

Martin Sean P.,Drake Justin,Wach Michael M.,Ruff Samantha M.,Diggs Laurence P.,Wan Jim Y.,Good Meghan L.,Dominguez Dana A.,Ayabe Reed I.,Glazer Evan S.,Dickson Paxton V.,Davis Jeremy L.,Deneve Jeremiah L.,Hernandez Jonathan M.

Funder

Intramural Research Program of the NIH

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference17 articles.

1. Forty-year trends in cholangiocarcinoma incidence in the U.S.: intrahepatic disease on the rise;Saha;Oncologist,2016

2. Cholangiocarcinoma - evolving concepts and therapeutic strategies;Rizvi;Nat Rev Clin Oncol,2018

3. Surgical resection of lymph node positive intrahepatic cholangiocarcinoma may not improve survival;Kizy;HPB,2019

4. The role of surgery and adjuvant therapy in lymph node-positive cancers of the gallbladder and intrahepatic bile ducts;Tran Cao;Cancer,2018

5. Value of lymph node dissection during resection of intrahepatic cholangiocarcinoma;Shimada;Br J Surg,2001

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Research progress and prospect of postoperative adjuvant therapy for resectable intrahepatic cholangiocarcinoma;Frontiers in Pharmacology;2024-08-07

2. Intrahepatic cholangiocarcinoma initially diagnosed as adenocarcinoma of unknown primary with hepatoduodenal ligament lymph node metastases: A case report;Oncology Letters;2023-11-08

3. Effect of combined application of apatinib and perioperative quality nursing based on Orem’s self-care theory in patients undergoing cholangiocarcinoma resection;Tropical Journal of Pharmaceutical Research;2023-02-17

4. CircSETD3 (hsa_circ_0000567) inhibits proliferation and induces apoptosis in cholangiocarcinoma cells via downregulation of microRNA-421 expression;Bioengineered;2022-04-01

5. Treatment of Intrahepatic Cholangiocarcinoma—A Multidisciplinary Approach;Cancers;2022-01-12